Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Sarcopenia With Underlying Osteoporosis
NCT06643780Phase 4Recruiting
- Sponsor
- Prince of Wales Hospital
- Start
- Apr 2024
- Primary completion
- Apr 2027
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in Sarcopenia, osteoporosis, sponsored by Prince of Wales Hospital. Started Apr 2024; status: recruiting.
02
Drugs
denosumab
03
Conditions
Sarcopeniaosteoporosis
Beyond the preview
Go deeper on NCT06643780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06643780.